Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2007 1
2009 1
2010 1
2011 8
2012 6
2013 9
2014 8
2015 5
2016 7
2017 14
2018 11
2019 7
2020 7
2021 16
2022 15
2023 18
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Inflammation in Coronary Microvascular Dysfunction.
Sagris M, Theofilis P, Antonopoulos AS, Oikonomou E, Paschaliori C, Galiatsatos N, Tsioufis K, Tousoulis D. Sagris M, et al. Int J Mol Sci. 2021 Dec 15;22(24):13471. doi: 10.3390/ijms222413471. Int J Mol Sci. 2021. PMID: 34948272 Free PMC article. Review.
This review focuses on the pathogenesis of coronary microvascular dysfunction and the capability of non-invasive screening methods to detect the phenomenon. Anti-inflammatory agents, such as statins and immunomodulators, including anakinra, tocilizumab, and tumor necrosis …
This review focuses on the pathogenesis of coronary microvascular dysfunction and the capability of non-invasive screening methods to detect …
C5a-licensed phagocytes drive sterilizing immunity during systemic fungal infection.
Desai JV, Kumar D, Freiwald T, Chauss D, Johnson MD, Abers MS, Steinbrink JM, Perfect JR, Alexander B, Matzaraki V, Snarr BD, Zarakas MA, Oikonomou V, Silva LM, Shivarathri R, Beltran E, Demontel LN, Wang L, Lim JK, Launder D, Conti HR, Swamydas M, McClain MT, Moutsopoulos NM, Kazemian M, Netea MG, Kumar V, Köhl J, Kemper C, Afzali B, Lionakis MS. Desai JV, et al. Cell. 2023 Jun 22;186(13):2802-2822.e22. doi: 10.1016/j.cell.2023.04.031. Epub 2023 May 22. Cell. 2023. PMID: 37220746
Systemic candidiasis is a common, high-mortality, nosocomial fungal infection. Unexpectedly, it has emerged as a complication of anti-complement C5-targeted monoclonal antibody treatment, indicating a critical niche for C5 in antifungal immunity. ...
Systemic candidiasis is a common, high-mortality, nosocomial fungal infection. Unexpectedly, it has emerged as a complication of anti …
Anti-inflammatory agents in peripheral arterial disease.
Antonopoulos AS, Papanikolaou E, Vogiatzi G, Oikonomou E, Tousoulis D. Antonopoulos AS, et al. Curr Opin Pharmacol. 2018 Apr;39:1-8. doi: 10.1016/j.coph.2017.11.001. Epub 2017 Nov 21. Curr Opin Pharmacol. 2018. PMID: 29169069 Review.
More recently, the reduction of cardiovascular events by use of an interleukin-1beta inhibitor (canakinumab) has revived interest in the use of anti-inflammatory agents for the treatment of atherosclerotic disease, including peripheral arterial disease. In this mini review …
More recently, the reduction of cardiovascular events by use of an interleukin-1beta inhibitor (canakinumab) has revived interest in the use …
The role of adipose tissue in cardiovascular health and disease.
Oikonomou EK, Antoniades C. Oikonomou EK, et al. Nat Rev Cardiol. 2019 Feb;16(2):83-99. doi: 10.1038/s41569-018-0097-6. Nat Rev Cardiol. 2019. PMID: 30287946 Review.
Systemic or local inflammation and insulin resistance lead to a shift in the adipose tissue secretome from anti-inflammatory and anti-atherogenic towards a pro-inflammatory and pro-atherogenic profile. ...
Systemic or local inflammation and insulin resistance lead to a shift in the adipose tissue secretome from anti-inflammatory and a …
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study.
Tabah A, Buetti N, Staiquly Q, Ruckly S, Akova M, Aslan AT, Leone M, Conway Morris A, Bassetti M, Arvaniti K, Lipman J, Ferrer R, Qiu H, Paiva JA, Povoa P, De Bus L, De Waele J, Zand F, Gurjar M, Alsisi A, Abidi K, Bracht H, Hayashi Y, Jeon K, Elhadi M, Barbier F, Timsit JF; EUROBACT-2 Study Group, ESICM, ESCMID ESGCIP and the OUTCOMEREA Network. Tabah A, et al. Intensive Care Med. 2023 Feb;49(2):178-190. doi: 10.1007/s00134-022-06944-2. Epub 2023 Feb 10. Intensive Care Med. 2023. PMID: 36764959 Free PMC article.
Novel Anti-Inflammatory Therapies in Coronary Artery Disease and Acute Coronary Syndromes.
Dimitroglou Y, Aggeli C, Theofilis P, Tsioufis P, Oikonomou E, Chasikidis C, Tsioufis K, Tousoulis D. Dimitroglou Y, et al. Life (Basel). 2023 Jul 31;13(8):1669. doi: 10.3390/life13081669. Life (Basel). 2023. PMID: 37629526 Free PMC article. Review.
These molecules can be targeted by commonly used therapeutic substances or selective molecules that exert targeted anti-inflammatory actions. The most significant anti-inflammatory therapies are aspirin, statins, colchicine, IL-1beta inhibitors, and IL-6 inhibitors, …
These molecules can be targeted by commonly used therapeutic substances or selective molecules that exert targeted anti-inflammatory …
The Anti-Inflammatory Effect of Novel Antidiabetic Agents.
Theofilis P, Sagris M, Oikonomou E, Antonopoulos AS, Siasos G, Tsioufis K, Tousoulis D. Theofilis P, et al. Life (Basel). 2022 Nov 9;12(11):1829. doi: 10.3390/life12111829. Life (Basel). 2022. PMID: 36362984 Free PMC article. Review.
Their widespread usage during the last three decades has raised awareness in the scientific community concerning their pleiotropic mechanisms of action, including their putative anti-inflammatory effect. In this review, we delve into the anti-inflammatory role and m …
Their widespread usage during the last three decades has raised awareness in the scientific community concerning their pleiotropic mechanism …
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
The primary objective of I-CARE (IBD Cancer and serious infections in Europe) was to assess prospectively safety concerns in IBD, with specific focus on the risk of cancer/lymphoma and serious infections in patients treated with anti-tumor necrosis factor and other biologi …
The primary objective of I-CARE (IBD Cancer and serious infections in Europe) was to assess prospectively safety concerns in IBD, with speci …
Thymosin β4 limits inflammation through autophagy.
Renga G, Oikonomou V, Stincardini C, Pariano M, Borghi M, Costantini C, Bartoli A, Garaci E, Goldstein AL, Romani L. Renga G, et al. Expert Opin Biol Ther. 2018 Jul;18(sup1):171-175. doi: 10.1080/14712598.2018.1473854. Expert Opin Biol Ther. 2018. PMID: 30063848 Review.
AREAS COVERED: The authors provide an overview of the Tbeta4's anti-inflammatory properties in several pathologies and provide preliminary evidence on the ability of Tbeta4 to resolve inflammation via the promotion of non-canonical autophagy associated with the activation …
AREAS COVERED: The authors provide an overview of the Tbeta4's anti-inflammatory properties in several pathologies and provide prelim …
118 results